What question did this study set out to answer?

To determine whether physiologic estradiol replacement therapy alters resting and exercise-induced cardiac structure and function in healthy postmenopausal women.

March 1, 1997Obstetrics and Gynecology

Physiologic estradiol replacement therapy and cardiac structure and function in normal postmenopausal women: A randomized, double-blind, placebo-controlled, crossover trial

View Full Paper

Ask AI

Bookmark

Why the study?

Does estradiol replacement therapy affect cardiac structure and function in healthy postmenopausal women?

Key Points

To determine whether physiologic estradiol replacement therapy alters resting and exercise-induced cardiac structure and function in healthy postmenopausal women.
Conducted a randomized, double-blind, placebo-controlled crossover trial in 31 healthy postmenopausal female volunteers aged 55 to 65 years.
Administered 12 weeks of micronized estradiol replacement therapy (2 mg/day) and matching placebo.
Evaluated cardiac dimensions and hemodynamics using echocardiography and Doppler techniques at rest and during graded bicycle ergometry.
Estradiol therapy elevated serum estradiol 15-fold to 37.6 pmol/L, with crossover analysis showing no carryover effects on measured cardiac parameters.
Estradiol produced no significant differences in systolic function, diastolic function, left ventricular mass, or pulmonary artery pressure at rest or during exercise.
Resting left ventricular end-diastolic volume was slightly higher with estradiol (P = .03), though stroke volume, ejection fraction, and cardiac output remained unchanged.

Structured PICO

Does estradiol replacement therapy affect cardiac structure and function in healthy postmenopausal women?

Population

31 healthy postmenopausal female volunteer study subjects (55-65 years)

Intervention

Micronized estradiol (E2) replacement therapy (2 mg/day) for 12 weeks

Comparator

Placebo (crossover design)

Outcome

Cardiac structure and function assessed by echocardiography and Doppler techniques at rest and during graded bicycle ergometrysurrogate

Physiologic estradiol replacement therapy for 12 weeks does not significantly alter cardiac structure or function in healthy postmenopausal women.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Reassures on cardiac safety of estradiol replacement in healthy postmenopausal women; confirms neutral effects on LV structure/function in this RCT.

Cite This Study

Snabes et al. (1997) studied this question.

synapsesocial.com/papers/6a154a72a2352da347823314 https://doi.org/10.1016/s0029-7844(96)00521-2

View Full Paper

Ask AI

Bookmark

Implication

Reassures on cardiac safety of estradiol replacement in healthy postmenopausal women; confirms neutral effects on LV structure/function in this RCT.

Physiologic estradiol replacement therapy and cardiac structure and function in normal postmenopausal women: A randomized, double-blind, placebo-controlled, crossover trial

Key Points

Structured PICO

Discussion

Implication

Cite This Study

Physiologic estradiol replacement therapy and cardiac structure and function in normal postmenopausal women: A randomized, double-blind, placebo-controlled, crossover trial

Key Points

Structured PICO

Discussion

Implication

Cite This Study

Also Consider

Also Consider